Gene · 4921
NIH grants1,545
NIH grants whose papers are about the gene, through NIH's grant-paper links.
641 to 660 of 1,545
Download this page as JSON| Grant | Title | DDR2 papers | Newest fiscal year |
|---|---|---|---|
| U19AI090023 | System Biological Analyses of Innate and Adaptive Responses to Vaccination | 1 | 2021 |
| U19AI131130 | Engineering a human brain organoid-based platform to study neurotropic viruses | 1 | 2021 |
| U24CA184427 | NDEx - the Network Data Exchange A Network Commons for Biologists | 1 | 2021 |
| U54CA156735 | NCCU-LCCC Partnership in Cancer Research | 1 | 2021 |
| U54CA209891 | Research Center for Cancer Systems Biology: Cancer Cell Map Initiative | 1 | 2021 |
| UH2CA239105 | Assay Validation of Cell-Free DNA Shallow Whole Genome Sequencing To Determine 'Tumor Fraction' in Advanced Cancers | 1 | 2021 |
| UH3DK114861 | Phenotyping REnal Cases In Sepsis and surgery for Early Acute Kidney Injury (PReCISE AKI) | 1 | 2021 |
| UH3DK114915 | Harvard Chronic Kidney Disease Research Biopsy Center | 1 | 2021 |
| UH3DK114926 | Kidney Precision Medicine Program (KPMP): Columbia AKI Recruitment Site | 1 | 2021 |
| UH3DK114937 | Multidimensional cellular interrogation of the kidney in AKI and CKD | 1 | 2021 |
| UH3EB025765 | Multi-tissue platform for modeling systemic pathologies | 1 | 2021 |
| ZIABC011124 | Oncogenic Met Signaling in Urologic Malignancies | 1 | 2021 |
| ZIAES103318 | Biomolecular Screening and Alternative Approaches for the Division of the National Toxicology Program | 1 | 2021 |
| R21DE029012 | Discoidin domain receptor 2, a novel regulator of bone regeneration | 8 | 2020 |
| R01HL108904 | Type I collagen signaling in lung injury and fibrosis | 4 | 2020 |
| U54CA210173 | The Johns Hopkins Physical Sciences Oncology Center | 4 | 2020 |
| U54CA210181 | Center for Immunotherapeutic Transport Oncophysics | 3 | 2020 |
| F31CA236245 | The role of mixed lineage leukemia (MLL/KMT2) core complex in directing FOXQ1 activity for triple negative breast cancer progression | 2 | 2020 |
| P30AG010129 | UC Davis Alzheimer's Disease Core Center | 2 | 2020 |
| P30AG013846 | Boston University Alzheimer's Disease Center | 2 | 2020 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/grants?page=33